Clearmind Medicine Inc. SEC filings CMND
Clearmind Medicine Inc. has 372 filings in SEC EDGAR's recent list, going back to Dec 23, 2021. Its latest annual report, Form 20-F, was filed on Jan 20, 2026 for the period ended Oct 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on October 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jan 20, 2026 | Oct 31, 2025 |
| 20-F | Annual report (foreign issuer) | Jan 22, 2025 | Oct 31, 2024 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 27, 2024 | Oct 31, 2023 |
| 20-F/A | Amended annual report (foreign issuer) | Mar 18, 2024 | Oct 31, 2023 |
| 20-F | Annual report (foreign issuer) | Jan 29, 2024 | Oct 31, 2023 |
| 20-F | Annual report (foreign issuer) | Feb 6, 2023 | Oct 31, 2022 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMND (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Vancouver, British Columbia, Canada (Federal Level)
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1892500
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.